Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-09-03

Privia Health Group (PRVA)

CEO Parth Mehrotra was paid $10,472,698 in fiscal year 2025, ↑ up 27.7% from fiscal year 2024, the 57th percentile of its disclosed peer group (SEC filing 0001193125-26-138997 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$10,472,698 ↑
Parth Mehrotra total, FY2025
57th
CEO pay percentile vs peers
168:1
CEO-to-median pay ratio
98.29%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Parth Mehrotra (Chief Executive Officer), FY2025 total compensation $10,472,698 (base salary $650,000) [exec_comp, SEC accession 0001193125-26-138997, filed 2026-04-02]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

PRVA's next annual pay disclosure, estimated March 31, 2027.est. Filing ↗

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Parth Mehrotra$650,000$0$8,588,373$0$1,218,750$0$15,575$10,472,698
Chief Executive Officer
David Mountcastle390,00002,147,0670468,000015,5753,020,642
Executive Vice President & Chief Financial Officer
Edward Fargis385,00001,610,3010346,500015,5752,357,376
Executive Vice President & General Counsel

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Parth Mehrotra$10,472,698$8,198,775$17,073,185↑ +2,273,923
David Mountcastle3,020,6422,937,8592,315,711↑ +82,783
Edward Fargis2,357,3763,215,424—↓ −858,048

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Privia Health Group's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper PRVA reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

How we handle your data → Privacy

Companies that benchmark against PRVA
11 companies name PRVA as a compensation peer

Each company listed discloses PRVA in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named PRVA in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Edward FargisGeneral Counsel$2,357,376
Parth MehrotraCEO$10,472,698
David MountcastleCFO$3,020,642
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
David KingChair of the Board$344,825
David WichmannIndependent Director$274,825
Jaewon RyuIndependent Director$276,203
Lance BerberianIndependent Director$173,893
Nancy CocozzaIndependent Director$274,825
Pamela KimmetIndependent Director$294,825
Patricia MarylandFormer director (through FY2025)$276,908
Shawn MorrisDirector$274,825
Thomas McCarthyIndependent Director$299,825
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
David MountcastleEVP & Chief Financial Officer2026-04-02D5,566$21$116,051CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D7,17925179,690CommonForm 4 ↗
Dividend-equivalent accruals2026-05-01—1,838——1 insider, 2 accrual rows
David MountcastleEVP & Chief Financial Officer2026-05-01A7,179214,358CommonForm 4 ↗
Shawn MorrisDirector2026-05-01D17,09600Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-05-01D17,09625427,229CommonForm 4 ↗
Shawn MorrisDirector2026-05-01A17,096234,192CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D2,33100Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D3,01000Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-05-04—2,223——2 insiders, 5 accrual rows
David MountcastleEVP & Chief Financial Officer2026-05-04A1,20622,412CommonForm 4 ↗
Shawn MorrisDirector2026-05-04D1,0172525,384CommonForm 4 ↗
Shawn MorrisDirector2026-05-04A1,01722,034CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D1,2062530,150CommonForm 4 ↗
Parth MehrotraDirector2026-05-11D105,439232,377,649CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-11D3,3852376,501CommonForm 4 ↗
Parth MehrotraDirector2026-05-12D15,64723354,248CommonForm 4 ↗
Pamela KimmetDirector2026-05-20A8,46300CommonForm 4 ↗
Jaewon RyuDirector2026-05-20A8,46300CommonForm 4 ↗
Shawn MorrisDirector2026-05-20A8,46300CommonForm 4 ↗
Francis S. Soistman JrDirector2026-05-20A8,46300CommonForm 4 ↗
David KingDirector2026-05-20A8,46300CommonForm 4 ↗
Thomas McCarthyDirector2026-05-20A8,46300CommonForm 4 ↗
Nancy CocozzaDirector2026-05-20A8,46300CommonForm 4 ↗
Lance BerberianDirector2026-05-20A8,46300CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D17,19625432,995CommonForm 4 ↗
Dividend-equivalent accruals2026-06-26—2,337——1 insider, 2 accrual rows
David MountcastleEVP & Chief Financial Officer2026-06-26D5,96200Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26A17,196234,392CommonForm 4 ↗
Shawn MorrisDirector2026-06-26A88,1102176,220CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D8,89700Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-26D88,11000Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-26D88,110252,231,826CommonForm 4 ↗
Shawn MorrisDirector2026-06-29A63,2122126,424CommonForm 4 ↗
Shawn MorrisDirector2026-06-29D63,21200Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-29D63,212251,601,160CommonForm 4 ↗
Shawn MorrisDirector2026-06-30D52,82300Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-30A52,8232105,646CommonForm 4 ↗
Shawn MorrisDirector2026-06-30D52,823261,358,608CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D82,67500Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D45,634271,210,214CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D37,04127997,514CommonForm 4 ↗
Shawn MorrisDirector2026-07-01A82,6752165,350CommonForm 4 ↗
Shawn MorrisDirector2026-07-02D59,037271,613,481CommonForm 4 ↗
Shawn MorrisDirector2026-07-02A59,0372118,074CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-02D24,73428680,185CommonForm 4 ↗
Shawn MorrisDirector2026-07-02D59,03700Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-06D53,72200Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-06D53,722271,463,387CommonForm 4 ↗
Shawn MorrisDirector2026-07-06A53,7222107,444CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-07D6002816,542CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-09D21,27528588,679CommonForm 4 ↗
Opella Finley ErnestDirector2026-09-01A6,35000CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 59 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
David MountcastleEVP & Chief Financial Officer2026-04-02D5,566$21$116,051CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D7,17925179,690CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D1,29700Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01A7,179214,358CommonForm 4 ↗
Shawn MorrisDirector2026-05-01D17,09600Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-05-01D17,09625427,229CommonForm 4 ↗
Shawn MorrisDirector2026-05-01A17,096234,192CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D2,33100Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D3,01000Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-01D54100Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D36000Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04A1,20622,412CommonForm 4 ↗
Shawn MorrisDirector2026-05-04D1,01700Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-05-04D1,0172525,384CommonForm 4 ↗
Shawn MorrisDirector2026-05-04A1,01722,034CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D59200Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D5200Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D20200Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-04D1,2062530,150CommonForm 4 ↗
Parth MehrotraDirector2026-05-11D105,439232,377,649CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-05-11D3,3852376,501CommonForm 4 ↗
Parth MehrotraDirector2026-05-12D15,64723354,248CommonForm 4 ↗
Pamela KimmetDirector2026-05-20A8,46300CommonForm 4 ↗
Jaewon RyuDirector2026-05-20A8,46300CommonForm 4 ↗
Shawn MorrisDirector2026-05-20A8,46300CommonForm 4 ↗
Francis S. Soistman JrDirector2026-05-20A8,46300CommonForm 4 ↗
David KingDirector2026-05-20A8,46300CommonForm 4 ↗
Thomas McCarthyDirector2026-05-20A8,46300CommonForm 4 ↗
Nancy CocozzaDirector2026-05-20A8,46300CommonForm 4 ↗
Lance BerberianDirector2026-05-20A8,46300CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D17,19625432,995CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D1,00100Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D5,96200Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26A17,196234,392CommonForm 4 ↗
Shawn MorrisDirector2026-06-26A88,1102176,220CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D8,89700Derivative, Class A CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-06-26D1,33600Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-26D88,11000Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-26D88,110252,231,826CommonForm 4 ↗
Shawn MorrisDirector2026-06-29A63,2122126,424CommonForm 4 ↗
Shawn MorrisDirector2026-06-29D63,21200Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-29D63,212251,601,160CommonForm 4 ↗
Shawn MorrisDirector2026-06-30D52,82300Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-06-30A52,8232105,646CommonForm 4 ↗
Shawn MorrisDirector2026-06-30D52,823261,358,608CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D82,67500Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D45,634271,210,214CommonForm 4 ↗
Shawn MorrisDirector2026-07-01D37,04127997,514CommonForm 4 ↗
Shawn MorrisDirector2026-07-01A82,6752165,350CommonForm 4 ↗
Shawn MorrisDirector2026-07-02D59,037271,613,481CommonForm 4 ↗
Shawn MorrisDirector2026-07-02A59,0372118,074CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-02D24,73428680,185CommonForm 4 ↗
Shawn MorrisDirector2026-07-02D59,03700Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-06D53,72200Derivative, Class A CommonForm 4 ↗
Shawn MorrisDirector2026-07-06D53,722271,463,387CommonForm 4 ↗
Shawn MorrisDirector2026-07-06A53,7222107,444CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-07D6002816,542CommonForm 4 ↗
David MountcastleEVP & Chief Financial Officer2026-07-09D21,27528588,679CommonForm 4 ↗
Opella Finley ErnestDirector2026-09-01A6,35000CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Parth MehrotraRSU2025-03-05——133,723—$3,435,344
David MountcastlePSU2025-03-0525,07350,146—100,2921,288,251
Parth MehrotraPSU2025-03-05100,293200,585—401,1705,153,029
Edward FargisPSU2025-03-0518,80537,609—75,218966,175
David MountcastleRSU2025-03-05——33,430—858,817
Edward FargisRSU2025-03-05——25,073—644,125
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Parth Mehrotra$3,435,344$5,153,029$060.0%
David Mountcastle858,8171,288,251060.0%
Edward Fargis644,125966,175060.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Edward FargisPSU42,816—$1,015,167
Parth MehrotraPSU133,723—3,170,572
David MountcastlePSU50,146—1,188,962
Edward FargisPSU19,030—451,201
Parth MehrotraPSU200,585—4,755,870
Parth MehrotraPSU5,173—122,652
Parth MehrotraPSU179,828—4,263,722
David MountcastlePSU25,373—601,594
Parth MehrotraPSU24,510—581,132
David MountcastleRSU39,856—955,458
Parth MehrotraPSU110,294—2,615,071
Parth MehrotraPSU79,924—1,894,998
David MountcastlePSU57,088—1,353,556
Edward FargisPSU44,404—1,052,819
Edward FargisPSU37,609—891,709
David MountcastlePSU33,430—792,625
David MountcastlePSU33,088—784,516
Edward FargisPSU25,073—594,481
Parth MehrotraPSU23,276—551,874
David MountcastlePSU7,353—174,340
David MountcastleOption16,22126.73—
Parth MehrotraPSU232,765—5,518,858
David MountcastlePSU12,209—289,475
05

Incentive-plan design — the Compensation Discussion & Analysis

In general, we strive to provide total compensation that meets the market median when executive officers are consistently meeting the full expectations of their role. Executive officers may be compensated above or below the targeted market position based on factors such as experience, performance, scope of position and the competitive demand for proven executive talent.

CEO STI target (% of salary)125%
CEO LTI target (% of salary)—
Independent consultantKorn Ferry (through September 2025), WTW (starting September 2025)
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-20103,956,5001,813,934105,44698.29%Passed
20252025-05-21105,145,8301,431,62941,56698.66%Passed
20242024-05-2296,616,30326,663,6184,660,43078.37%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2098.29%a
20252025-05-2198.66%b
20242024-05-2278.37%c

a. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.

b. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.

c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of this proposal.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)168 : 1
CEO total compensation$10,472,698
Median employee compensation$62,334
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
David KingIndependent · Board Chair · Compensation · Nominating and Corporate Governance (Chair)$145,000$199,825$0$0$0$344,825
Thomas McCarthyIndependent · Audit (Chair)100,000199,825000299,825
Pamela KimmetIndependent · Compensation (Chair) · Nominating and Corporate Governance95,000199,825000294,825
Patricia MarylandIndependent · Compliance · Departed during FY77,083199,825000276,908
Jaewon RyuIndependent · Compliance (Chair)76,458199,82500—276,203
Shawn MorrisNot independent · Compliance75,000199,825000274,825
David WichmannIndependent · Audit · Compensation · Not standing for re-election75,000199,825000274,825
Nancy CocozzaIndependent · Audit · Nominating and Corporate Governance75,000199,825000274,825
Lance BerberianIndependent · Audit · Compliance · Newly elected15,625158,268000173,893
Parth MehrotraEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$75,000
Annual equity retainer$199,825
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 15,000
Stock ownership guideline$375,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$734,166
Equity awards (grant-date value)$1,756,868
All other compensation$0
Total cost of the board$2,491,034

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Privia Health Group names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Privia Health Group.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Goodrx Holdings, Inc.2025Wendy Barnes$825,000$10,921,182$9,000,000$0$23,367,483
2Astrana Health, Inc.2025Brandon Sim850,00011,999,98002,059,12514,930,231
3Evolent Health, Inc.2025Seth Blackley867,06812,699,0860014,240,154
4Premier, Inc.2024Michael Alkire1,095,8768,500,03901,800,15011,806,381
5Alignment Healthcare, Inc.2025John Kao833,6548,500,01401,944,49511,278,583
6Teladoc Health, Inc.2025Charles Divita, III800,0009,699,9960584,00011,202,996
7Privia Health Group2025Parth Mehrotra650,0008,588,37301,218,75010,472,698
8Claritev Corporation (f/k/a Multiplan Corporation)2025Travis Dalton825,0008,234,54201,134,37510,202,667
9Phreesia, Inc.2026Chaim Indig515,0007,562,706008,077,706
10Lifestance Health Group, Inc.2025David Bourdon657,6925,257,6230716,0656,645,380
11Surgery Partners, Inc.2025J. Eric Evans1,050,0005,000,000006,083,862
12Agilon Health, Inc.2025Jeffrey Schwaneke625,0002,950,0031,750,000271,8755,610,878
13Health Catalyst, Inc.2025Daniel Burton525,0003,444,040003,991,159
14Accolade, Inc.2024Rajeev Singh500,0003,320,097003,823,597
15Oscar Health, Inc.2025Mark Bertolini619,17800169,0361,149,308

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Privia Health Group150%PSU 60 · RSU 40NoKorn Ferry (through September 2025), WTW (starting September 2025)
Accolade, Inc.not disclosedPSU 50 · RSU 50NoFW Cook
Agilon Health, Inc.58%not disclosedNoSemler Brossy
Alignment Healthcare, Inc.200%not disclosedNoFW Cook
Astrana Health, Inc.193.8%PSU 67 · RSU 33NoPearl Meyer
Claritev Corporation (f/k/a Multiplan Corporation)110%Cash LTI 75 · RSU 25not disclosedKorn Ferry
Evolent Health, Inc.75%PSU 70 · RSU 30NoExequity
Goodrx Holdings, Inc.not disclosednot disclosednot disclosedPay Governance
Health Catalyst, Inc.39%RSU 50 · PSU 50Yes — TSR AchievementAon (Human Capital Solutions practice)
Lifestance Health Group, Inc.not disclosednot disclosednot disclosedPay Governance
Oscar Health, Inc.91.0%PSU 50 · RSU 50Yes — Relative TSRFW Cook
Phreesia, Inc.140.3%PSU 50 · RSU 50Yes — Relative TSRFW Cook, Inc.
Premier, Inc.109.1%PSU 60 · RSU 40NoMercer
Surgery Partners, Inc.not disclosedPSU 60 · Restricted Stock 40NoFrederic W. Cook & Co., Inc. (FW Cook)
Teladoc Health, Inc.73%RSU 50 · PSU 50NoAon

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Privia Health Group in fiscal 2025?
As disclosed, Parth Mehrotra (Chief Executive Officer) was the highest-paid executive at Privia Health Group in fiscal 2025, with total compensation of $10,472,698.
How does Privia Health Group's chief executive pay compare to its disclosed peer group?
As disclosed, Parth Mehrotra's total compensation ranked at the 57th percentile of Privia Health Group's disclosed peer group.
What is Privia Health Group's CEO-to-median employee pay ratio?
As disclosed, Privia Health Group's CEO-to-median employee pay ratio was 168:1.
How did shareholders vote on Privia Health Group's executive compensation?
As disclosed, 98.29% of shareholders supported Privia Health Group's executive compensation in the latest say-on-pay vote.
How much does Privia Health Group spend in total on board compensation for fiscal 2025?
As disclosed, Privia Health Group reported total board compensation of $2,491,034 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Parth MehrotraDEF 14A2026-04-020001193125-26-138997Section “2025 Summary Compensation Table” · page 37. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915
2Section 01, David MountcastleDEF 14A2026-04-020001193125-26-138997Section “2025 Summary Compensation Table” · page 37. As printed: 3,020,642. Filing ↗machine: span 546861–546870
3Section 01, Edward FargisDEF 14A2026-04-020001193125-26-138997Section “2025 Summary Compensation Table” · page 37. As printed: 2,357,376. Filing ↗machine: span 554919–554928
4Section 03, Parth Mehrotra RSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r4 · c44 · span 575929–575938
5Section 03, David Mountcastle PSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r8 · c44 · span 585962–585971
6Section 03, Parth Mehrotra PSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r5 · c44 · span 578411–578420
7Section 03, Edward Fargis PSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r11 · c44 · span 595130–595137
8Section 03, David Mountcastle RSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r7 · c44 · span 583509–583516
9Section 03, Edward Fargis RSUDEF 14A2026-04-020001193125-26-138997Section “EXECUTIVE COMPENSATION TABLES &” · grants of plan-based awards table. Filing ↗machine: t173 · r10 · c44 · span 591064–591071
10Section 07, pay ratioDEF 14A2026-04-020001193125-26-138997Section “CEO Pay Ratio”. As printed: 168 : 1. Filing ↗
11Section 08, David KingDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 344,825. Filing ↗machine: t233 · r6 · c14 · span 905798–905805
12Section 08, Thomas McCarthyDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 299,825. Filing ↗machine: t233 · r8 · c14 · span 907800–907807
13Section 08, Pamela KimmetDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 294,825. Filing ↗machine: t233 · r5 · c14 · span 904790–904797
14Section 08, Patricia MarylandDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 276,908. Filing ↗machine: t233 · r7 · c14 · span 906787–906794
15Section 08, Jaewon RyuDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 276,203. Filing ↗machine: t233 · r10 · c14 · span 909792–909799
16Section 08, Shawn MorrisDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r9 · c14 · span 908784–908791
17Section 08, David WichmannDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r11 · c14 · span 911307–911314
18Section 08, Nancy CocozzaDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 274,825. Filing ↗machine: t233 · r4 · c14 · span 903805–903812
19Section 08, Lance BerberianDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 173,893. Filing ↗machine: t233 · r2 · c14 · span 901696–901703
20Section 08, Parth MehrotraDEF 14A2026-04-020001193125-26-138997Section “Director Compensation”. As printed: 0. Filing ↗
21Section 02, David Mountcastle 2026-04-02Form 42026-04-060001858396-26-000006Insider equity transaction reported since the proxy statement. Filing ↗
22Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
23Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
24Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
25Section 02, Shawn Morris 2026-05-01Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
26Section 02, Shawn Morris 2026-05-01Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
27Section 02, Shawn Morris 2026-05-01Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
28Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
29Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
30Section 02, David Mountcastle 2026-05-01Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
31Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
32Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Shawn Morris 2026-05-04Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Shawn Morris 2026-05-04Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Shawn Morris 2026-05-04Form 42026-05-050001759655-26-000020Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, David Mountcastle 2026-05-04Form 42026-05-050001858396-26-000009Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Parth Mehrotra 2026-05-11Form 42026-05-130001759655-26-000030Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, David Mountcastle 2026-05-11Form 42026-05-130001858396-26-000011Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Parth Mehrotra 2026-05-12Form 42026-05-130001759655-26-000030Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Pamela Kimmet 2026-05-20Form 42026-05-220001759655-26-000041Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Jaewon Ryu 2026-05-20Form 42026-05-220001759655-26-000038Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Shawn Morris 2026-05-20Form 42026-05-220001759655-26-000039Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Francis S. Soistman Jr 2026-05-20Form 42026-05-220001759655-26-000044Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, David King 2026-05-20Form 42026-05-220001759655-26-000037Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Thomas McCarthy 2026-05-20Form 42026-05-220001759655-26-000040Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Nancy Cocozza 2026-05-20Form 42026-05-220001759655-26-000042Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Lance Berberian 2026-05-20Form 42026-05-220001759655-26-000043Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Shawn Morris 2026-06-26Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, David Mountcastle 2026-06-26Form 42026-06-300001759655-26-000046Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Shawn Morris 2026-06-26Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Shawn Morris 2026-06-26Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Shawn Morris 2026-06-29Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Shawn Morris 2026-06-29Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Shawn Morris 2026-06-29Form 42026-06-300001759655-26-000048Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Shawn Morris 2026-06-30Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Shawn Morris 2026-06-30Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Shawn Morris 2026-06-30Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Shawn Morris 2026-07-01Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Shawn Morris 2026-07-01Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, Shawn Morris 2026-07-01Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Shawn Morris 2026-07-01Form 42026-07-020001759655-26-000053Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Shawn Morris 2026-07-02Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Shawn Morris 2026-07-02Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, David Mountcastle 2026-07-02Form 42026-07-070001858396-26-000014Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Shawn Morris 2026-07-02Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Shawn Morris 2026-07-06Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Shawn Morris 2026-07-06Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Shawn Morris 2026-07-06Form 42026-07-070001401958-26-000010Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, David Mountcastle 2026-07-07Form 42026-07-090001858396-26-000016Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, David Mountcastle 2026-07-09Form 42026-07-130001759655-26-000057Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Opella Finley Ernest 2026-09-01Form 42026-09-030001759655-26-000076Insider equity transaction reported since the proxy statement. Filing ↗
80Section 06, 2026 voteForm 8-K2026-05-220001759655-26-000034Item 5.07 · say-on-pay result. As reported: 98.29% (votes for as printed: 103,956,500). Filing ↗
81Section 06, 2025 voteForm 8-K2025-05-220001759655-25-000056Item 5.07 · say-on-pay result. As reported: 98.66% (votes for as printed: 105,145,830). Filing ↗
82Section 06, 2024 voteForm 8-K2024-05-230001759655-24-000076Item 5.07 · say-on-pay result. As reported: 78.37% (votes for as printed: 96,616,303). Filing ↗
83Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
84Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
85Section 09b board cost (computed)Computed——Cash 734,166 + equity 1,756,868 + all other 0 = 2,491,034, summed across the director compensation table rows.machine: formula: Σ = 2,491,034
86Goodrx Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-290001809519-26-000091CEO total compensation as printed in Goodrx Holdings, Inc.'s own proxy. As printed: 23,367,483. Filing ↗machine: r2 · c16 · span 1286734–1286744
87Astrana Health, Inc., Section 10b CEO totalDEF 14A2026-04-170001104659-26-044536CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. Filing ↗machine: span 525189–525199
88Evolent Health, Inc., Section 10b CEO totalDEF 14A2026-04-240001193125-26-177267CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. Filing ↗machine: r3 · c20 · span 908544–908555
89Premier, Inc., Section 10b CEO totalDEF 14A2024-10-210001193125-24-240399CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. Filing ↗machine: span 1173351–1173361
90Alignment Healthcare, Inc., Section 10b CEO totalDEF 14A2026-04-240001628280-26-027058CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838
91Teladoc Health, Inc., Section 10b CEO totalDEF 14A2026-04-070001477449-26-000020CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486
92Privia Health Group (subject), Section 10b CEO totalDEF 14A2026-04-020001193125-26-138997CEO total compensation as printed in Privia Health Group's own proxy. As printed: 10,472,698. Filing ↗machine: t166 · r3 · c39 · span 538905–538915
93Claritev Corporation (f/k/a Multiplan Corporation), Section 10b CEO totalDEF 14A2026-03-200001793229-26-000027CEO total compensation as printed in Claritev Corporation (f/k/a Multiplan Corporation)'s own proxy. As printed: 10,202,667. Filing ↗machine: r3 · c30 · span 707237–707247
94Phreesia, Inc., Section 10b CEO totalDEF 14A2026-05-140001412408-26-000155CEO total compensation as printed in Phreesia, Inc.'s own proxy. As printed: 8,077,706. Filing ↗machine: span 634967–634976
95Lifestance Health Group, Inc., Section 10b CEO totalDEF 14A2026-04-220001193125-26-170798CEO total compensation as printed in Lifestance Health Group, Inc.'s own proxy. As printed: 6,645,380. Filing ↗machine: r2 · c27 · span 745884–745893
96Surgery Partners, Inc., Section 10b CEO totalDEF 14A2026-04-230001638833-26-000039CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872
97Agilon Health, Inc., Section 10b CEO totalDEF 14A2026-04-220001628280-26-026544CEO total compensation as printed in Agilon Health, Inc.'s own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326
98Health Catalyst, Inc., Section 10b CEO totalDEF 14A2026-06-030001636422-26-000075CEO total compensation as printed in Health Catalyst, Inc.'s own proxy. As printed: 3,991,159. Filing ↗machine: span 702084–702093
99Accolade, Inc., Section 10b CEO totalDEF 14A2024-06-210001481646-24-000029CEO total compensation as printed in Accolade, Inc.'s own proxy. As printed: 3,823,597. Filing ↗machine: r2 · c42 · span 399607–399616
100Oscar Health, Inc., Section 10b CEO totalDEF 14A2026-04-220001140361-26-016119CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. Filing ↗machine: t173 · r2 · c25 · span 1052592–1052601
101Section 10a, Teladoc Health, Inc. reciprocityDEF 14A—0001477449-26-000020Teladoc Health, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗
102Section 10a, Claritev Corporation (f/k/a Multiplan Corporation) reciprocityDEF 14A—0001793229-26-000027Claritev Corporation (f/k/a Multiplan Corporation)'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
103Section 10a, Health Catalyst, Inc. reciprocityDEF 14A—0001636422-26-000075Health Catalyst, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
104Section 10a, Surgery Partners, Inc. reciprocityDEF 14A—0001638833-26-000039Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
105Section 10a, Evolent Health, Inc. reciprocityDEF 14A—0001193125-26-177267Evolent Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
106Section 10a, Accolade, Inc. reciprocityDEF 14A—0001481646-24-000029Accolade, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
107Section 10a, Goodrx Holdings, Inc. reciprocityDEF 14A—0001809519-26-000091Goodrx Holdings, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗
108Section 10a, Phreesia, Inc. reciprocityDEF 14A—0001412408-26-000155Phreesia, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗
109Section 10a, Agilon Health, Inc. reciprocityDEF 14A—0001628280-26-026544Agilon Health, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗
110Section 10a, Premier, Inc. reciprocityDEF 14A—0001193125-24-240399Premier, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
111Section 10a, Alignment Healthcare, Inc. reciprocityDEF 14A—0001628280-26-027058Alignment Healthcare, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗
112Section 10a, Oscar Health, Inc. reciprocityDEF 14A—0001140361-26-016119Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Privia Health Group. Filing ↗
113Section 10a, Lifestance Health Group, Inc. reciprocityDEF 14A—0001193125-26-170798Lifestance Health Group, Inc. names Privia Health Group in its own disclosed peer group (read from its most recent proxy). Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.